divvy, page-18

The dividend was woeful?... What if its 2c for the second half, would that be woeful too?
This co. is racing the clock a bit now. They have to embed (trendy new word used a lot by politicians, journos, bricklayers) the product into the health systems of the developed world well before their patents expire so Quantiferon is the generic term, and they stay at the top of the heap. I know there is no heap yet but there will be, so any funds spent on PR is well spent in my opinion. And if we end up getting a 1.5% div. for the year, I won't be complaining.